# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mary Shelley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI028-SYN-TD
- Date: 1849-04-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rosamund Achterberg-Ilesanmi, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Review three weeks after craniotomy, with the pathology. **S**

## History of present illness

Ms. Shelley returns three weeks after a left frontoparietal craniotomy. The tumor was removed completely with its dural attachment and a margin of dura (Simpson grade I), and the MRI the next day showed no residual tumor. The pathology is a meningothelial meningioma, CNS WHO grade 1: one mitosis per ten high-power fields, no brain invasion, no atypical features, Ki-67 3 percent, and no TERT promoter mutation or CDKN2A/B deletion. Her right hand was weaker for the first two days after surgery and has been improving steadily. She took dexamethasone for three days before surgery and stopped the taper eleven days ago. She has had no seizure since starting levetiracetam six weeks ago. She notices that she is short-tempered and tearful at times, which she links to the tablets as much as to the operation, and she has seen the counselor twice. The wound has healed and the staples are out. She has begun to write for half an hour a day. **S**

| Element | Detail |
|---|---|
| Surgery | Simpson grade I resection; gross total on MRI the next day |
| Pathology | Meningothelial meningioma, CNS WHO grade 1 |
| Seizures | None since starting levetiracetam |
| Steroid | Dexamethasone stopped eleven days ago |
| Mood | Irritable and tearful at times; two counselor sessions |
| Writing | Half an hour a day |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Right hand weaker than before surgery for two days, now improving; no seizures; mild incision headache |
| Integumentary | Negative | Wound healed; no discharge |
| Endocrine | Negative | No thirst or frequent urination after the steroid |
| Psychiatric | Positive | Irritability and tearfulness; no thoughts of suicide |

4 systems reviewed. **S**

## Current medications

- Levetiracetam 500 mg oral tablet, one tablet by mouth twice a day **S**
- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for headache or wound pain, no more than 3000 mg a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/76 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 58.1 kg; BMI 22.7 kg/m². All vital signs are synthetic.

Glucose: 96 mg/dL; Sodium: 138 mmol/L; Hemoglobin: 12.1 g/dL; PHQ-9: 9. All results are synthetic.

## Change since baseline

- Glucose: 91 mg/dL at baseline, 96 mg/dL at this visit **S**
- Sodium: 139 mmol/L at baseline, 138 mmol/L at this visit **S**
- Hemoglobin: 12.8 g/dL at baseline, 12.1 g/dL at this visit **S**
- PHQ-9: 7 at baseline, 9 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; hair regrowing over the incision |
| Head | Left frontoparietal incision healed; no swelling or fluid |
| Neurological | Speech fluent; right grip 4+/5 and slower finger tapping on the right; no drift; reflexes slightly brisk on the right; gait normal |
| Mental status | Mood "short-tempered and weepy"; affect reactive; no thoughts of suicide |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Meningioma, CNS WHO grade 1, after Simpson grade I resection** (D32.0). Complete resection of a grade 1 meningioma; the risk of recurrence is low, and radiation would add harm without clear benefit, so none is given. Glucose 96 mg/dL and sodium 138 mmol/L after the steroid course; hemoglobin 12.1 g/dL. **S**
   - No radiation.
   - MRI with gadolinium at three months, then yearly for five years, then every two years.
   - Occupational therapy for fine hand movements, twice a week for four weeks.
2. **Focal epilepsy on levetiracetam** (G40.109). Seizure-free for six weeks. PHQ-9 9 with irritability that may be a levetiracetam effect. Options discussed: continue and watch, a lower dose, or a switch to another medicine such as lacosamide. She chose to continue for now, because the seizures stopped and she does not want a change before the three-month scan. **S**
   - Continue levetiracetam 500 mg twice a day for at least a year after surgery.
   - Call if irritability or low mood worsens, or at once for any thoughts of self-harm; the switch remains open.
   - No driving yet.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | MRI within 48 hours after surgery | Within 48 hours of resection | Up to date | The day after surgery: gross total resection |
| Laboratory | WHO CNS5 grading of the resected tumor (mitoses, brain invasion, histological subtype, TERT promoter, CDKN2A/B) | On the surgical specimen | Up to date | Meningothelial meningioma, CNS WHO grade 1; no TERT promoter mutation or CDKN2A/B deletion |
| Referral | Radiation oncology | After resection of grade 2 or 3 tumors, or incomplete resection with symptoms | Not indicated | Grade 1 after Simpson grade I resection |
| Laboratory | Glucose and sodium after corticosteroid and craniotomy | After a steroid course and intracranial surgery | Completed today | Glucose 96 mg/dL, sodium 138 mmol/L, hemoglobin 12.1 g/dL |
| Medication safety | Corticosteroid stopped as soon as possible | Shortest course | Completed today | Dexamethasone stopped eleven days ago after a ten-day taper |
| Self-management | Seizure diary, triggers (sleep loss, alcohol, missed doses), and seizure first aid | Every visit | Completed today | No seizures since levetiracetam was started; regular sleep kept |
| Survey | PHQ-9, with a question about irritability on levetiracetam | Every visit while on levetiracetam and during cancer treatment | Completed today | 9, with irritability and tearfulness; two counselor sessions; continuing levetiracetam by her choice with a low threshold to switch |
| Survey | GAD-7 | Every visit during the diagnostic and treatment phase | Deferred | Missed at the second visit and again today; the PHQ-9 was done each time and the counselor is assessing anxiety, so no harm is judged to have resulted. Corrective action: the GAD-7 is added to the visit template and will be done at the next visit |
| Self-management | Driving | Until seizure-free for the state's required period and cleared after craniotomy | Completed today | Not driving |
| Referral | Occupational therapy for hand function | If weakness persists after surgery | Ordered | Twice a week for four weeks |

## Goal progress

- A diagnosis within two weeks, explained in plain words with the images and reports. Outcome by 1849-03-17: MRI and EEG within a week; diagnosis explained at two weeks with the images. **S**
- No further seizures. In progress; target 1850-04-07. **S**
- Full use of the right hand and return to writing every morning. In progress; target 1849-09-29. **S**
- Decide on treatment herself after hearing the options, benefits, and harms. Outcome by 1849-03-17: Chose resection after observation and radiosurgery were explained. **S**
- Mood and grief supported: PHQ-9 below 5 and a counselor available. In progress; target 1849-09-29. **S**

## Guideline basis

- EANO guideline on the diagnosis and management of meningiomas. Goldbrunner R, et al. Neuro Oncol 2021;23(11):1821-1834 (2021), European Association of Neuro-Oncology
- NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers, Version 2.2025 (2025), National Comprehensive Cancer Network
- Evidence-based guideline: Management of an unprovoked first seizure in adults. Krumholz A, et al. Neurology 2015;84(16):1705-1713 (2015), American Academy of Neurology and American Epilepsy Society
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (depression screening and PHQ-9 follow-up) (2026), Aether Forge

## Follow-up

- Occupational therapy twice a week; counselor fortnightly; MRI at three months and review a few days later. **S**
- Next scheduled visit 1849-07-07: three-month MRI review after resection. **S**
